Pharmafile Logo
Pharmafocus logo
Advanced Search

UK begins swine flu vaccinations with GSK jab

October 21, 2009
Sales and Marketing h1n1, hc

The UK's swine flu vaccination programme began today with NHS hospitals offering the jabs to frontline healthcare workers and patients …

News

Lonza looking elsewhere after retreating from Patheon bid?

October 21, 2009
Manufacturing and Production Lonza

 Lonza said it has elected not to proceed with a $460 million bid to buy Canadian contract manufacturing and development …

News

Andrew Sandham, executive chairman, Syntaxin

October 20, 2009
Research and Development appointment, appointments, research and development, syntaxin

Syntaxin, a biopharmaceutical company developing novel biologic drugs that control cell secretion, has appointed Andrew Sandham executive chairman.This follows the …

Appointment
Cellectis Sylvie

Cellectis appoints Dr Sylvie Delassus Senior Vice President Communications

October 20, 2009
Research and Development appointment, cellectis, research and development

French genome engineering company Cellectis has appointed Dr Sylvie Delassus senior vice president communications and a member of its executive …

Appointment
Blog footer

Digital Pharma: Raising awareness of clinical trials

October 20, 2009
Medical Communications, Research and Development CRO, Quintiles, digi, digital pharma, digital research, patient recruitment

Contract research organisation Quintiles has launched a website for people considering participating in clinical trials. The company hopes Clinicalresearch.com will …

Feature

Digital Pharma: Byte-sized roundup

October 20, 2009
Medical Communications digi

Feature

GSK kidney cancer drug approved in US

October 20, 2009
Research and Development, Sales and Marketing Cancer, GSK, rcc

 GlaxoSmithKline’s Votrient has been approved in the US by the FDA to treat the most common form of kidney cancer.This …

News

First details emerge of Pfizer site closures

October 20, 2009
Research and Development, Sales and Marketing MA, Pfizer, restructure

 The completion of Pfizer’s deal to acquire Wyeth has been followed swiftly by news that a number of manufacturing and …

News
Fishawack Gail

Gail Flockhart joins Fishawack Communications as managing director

October 19, 2009
Medical Communications appointment, appointment fishawack, fishawack, medical communications

Fishawack Communications has appointed Gail Flockhart managing director following a restructure of its board of directors.Gail has over two decades …

Appointment

Cambridge biotech – innovation and global partnerships

October 19, 2009
Research and Development Cambridge, ERBI, biotech, regenerative medicine

Just two years ago it cost $10m to sequence a human genome, now for $48,000 you can have a personal …

Feature

GSK’s Cervarix finally wins US approval

October 19, 2009
Sales and Marketing Cervarix, GSK, US

US regulator the FDA has approved GlaxoSmithKline's cervical cancer vaccine Cervarix, finally allowing the company to bring it to the …

News

Pharma manufacturing news in brief

October 19, 2009
Manufacturing and Production Neopharma

A round-up of developments in the pharmaceutical manufacturing sector, with facility updates from Neopharma, Nextpharma and Arch Pharmalab and new …

News

AZ-BMS launch Onglyza in Europe

October 19, 2009
Sales and Marketing AZ, BMS, DPP-4, Onglyza, diabetes

 Bristol-Myers Squibb and AstraZeneca’s long-awaited type II diabetes drug Onglyza has been launched in the UK, its first European market.Designed …

News
Athena Hannah

Hannah Stacey, senior account manager, Athena

October 16, 2009
Medical Communications Athena, appointment, medical communications

Athena has promoted Hannah Stacey to senior account manager. Hannah has played an integral role in Athena’s new business initiatives …

Appointment

Digital Pharma: Byte-sized roundup

October 16, 2009
Medical Communications Merck, digi, digital pharma, hcsmeu, iphone

   

Feature

Quality regulator slams NHS trusts

October 16, 2009
Sales and Marketing NHS, hc

The Care Quality Commission has slammed nearly 50 NHS trusts in its latest annual report on the care which patients …

News

Johnson & Johnson rides out patent attack

October 16, 2009
Sales and Marketing JJ, generics

 Profits at Johnson & Johnson have risen in the third quarter, despite deep cuts into pharma sales caused by new …

News

Lilly finds buyer for threatened manufacturing unit

October 16, 2009
Manufacturing and Production Evonik, lilly

 Lilly has found a buyer for its manufacturing facility Tippecanoe Laboratories in Indiana, USA, which had been under threat of …

News
LisaRojkjaer100

Dr Lisa Rojkjaer, head of clinical development, MorphoSys

October 15, 2009
Research and Development appointment, morphosys, research and development

MorphoSys has appointed Dr Lisa Rojkjaer as vice president and head of clinical development. Dr Rojkjaer joins MorphoSys from Novartis …

Appointment
LindaDyson100

Linda Dyson, global healthcare practice leader, Cohn & Wolfe

October 15, 2009
Medical Communications Cohn & Wolfe, appointment, medical communications

Cohn & Wolfe has appointed Linda Dyson as executive vice president and global healthcare practice leader. She will report to …

Appointment
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026